Reversal of multidrug resistance phenotype in human breast cancer cells using doxorubicin-liposome-microbubble complexes assisted by ultrasound

Journal of Controlled Release

Volumn 174, Issue 1, 2014, Pages 109-116

  Deng, Zhiting ^a   Yan, Fei ^a   Jin, Qiaofeng ^a   Li, Fei ^a   Wu, Junru ^b   Liu, Xin ^a   Zheng, Hairong ^a  

^a INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

^b University of Vermont   (United States)

Author keywords

Doxorubicin; Doxorubicin liposome microbubble complexes; Drug delivery; Multidrug resistance; Ultrasound

Indexed keywords

BIOTIN-AVIDIN LINKAGE; DOXORUBICIN; DOXORUBICIN-LIPOSOME-MICROBUBBLE COMPLEXES; HUMAN BREAST CANCER CELLS; MECHANISM INVESTIGATION; MULTIDRUG RESISTANCE; NUCLEAR ACCUMULATION; REACTIVE OXYGEN SPECIES;

CHEMOTHERAPY; CYTOLOGY; DRUG DELIVERY; GLYCOPROTEINS; PHARMACODYNAMICS; ULTRASONICS;

CELLS;

DOXORUBICIN; LIPOSOME; REACTIVE OXYGEN METABOLITE; VERAPAMIL;

APOPTOSIS; ARTICLE; BREAST CANCER; CANCER RESISTANCE; CELL CULTURE; CELL VIABILITY; CELLULAR DISTRIBUTION; CONFOCAL LASER MICROSCOPY; CONFOCAL MICROSCOPY; DNA DAMAGE; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; MICROBUBBLE; MULTIDRUG RESISTANCE; PHENOTYPE; PRIORITY JOURNAL; ULTRASOUND; WESTERN BLOTTING;

DOXORUBICIN; DOXORUBICIN-LIPOSOME-MICROBUBBLE COMPLEXES; DRUG DELIVERY; MULTIDRUG RESISTANCE; ULTRASOUND;

BREAST NEOPLASMS; CELL LINE, TUMOR; CELL SURVIVAL; DNA DAMAGE; DOXORUBICIN; DRUG DELIVERY SYSTEMS; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; FEMALE; HISTONES; HUMANS; IN SITU NICK-END LABELING; MICROBUBBLES; POLYETHYLENE GLYCOLS; REACTIVE OXYGEN SPECIES; ULTRASONICS;

EID: 84888989454     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2013.11.018     Document Type: Article

References (35)

1. E.A. Perez Impact, mechanisms, and novel chemotherapy strategies for overcoming resistance to anthracyclines and taxanes in metastatic breast cancer Breast Cancer Res. Treat. 114 2009 195 201
2. M.M. Gottesman How cancer-cells evade chemotherapy - 16th Richard-and-Hinda-Rosenthal-Foundation Award Lecture Cancer Res. 53 1993 747 754 (Pubitemid 23077856)
3. G. Szakacs, J.K. Paterson, J.A. Ludwig, C. Booth-Genthe, and M.M. Gottesman Targeting multidrug resistance in cancer Nat. Rev. Drug Discov. 5 2006 219 234 (Pubitemid 43336035)
4. C.H. Lee Reversing agents for ATP-binding cassette drug transporters Methods Mol. Biol. 596 2010 325 340
5. T. Tsuruo, H. Iida, S. Tsukagoshi, and Y. Sakurai Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil Cancer Res. 41 1981 1967 1972 (Pubitemid 11114605)
6. P.R. Twentyman, N.E. Fox, and D.J.G. White Cyclosporine-a and its analogs as modifiers of adriamycin and vincristine resistance in a multidrug resistant human-lung cancer cell-line Br. J. Cancer 56 1987 55 57 (Pubitemid 17097699)
7. A.H. Dantzig, K.L. Law, J. Cao, and J.J. Starling Reversal of multidrug resistance by the P-glycoprotein modulator, LY335979, from the bench to the clinic Curr. Med. Chem. 8 2001 39 50
8. L.M. Pan, J.A. Liu, Q.J. He, L.J. Wang, and J.L. Shi Overcoming multidrug resistance of cancer cells by direct intranuclear drug delivery using TAT-conjugated mesoporous silica nanoparticles Biomaterials 34 2013 2719 2730
9. F. Yan, C. Zhang, Y. Zheng, L. Mei, L. Tang, C. Song, H. Sun, and L. Huang The effect of poloxamer 188 on nanoparticle morphology, size, cancer cell uptake, and cytotoxicity Nanomedicine 6 2010 170 178
10. A. Kheirolomoom, P.A. Dayton, A.F. Lum, E. Little, E.E. Paoli, H. Zheng, and K.W. Ferrara Acoustically-active microbubbles conjugated to liposomes: characterization of a proposed drug delivery vehicle J. Control. Release 118 2007 275 284 (Pubitemid 46441545)
11. S. Mehier-Humbert, T. Bettinger, F. Yan, and R.H. Guy Plasma membrane poration induced by ultrasound exposure: implication for drug delivery J. Control. Release 104 2005 213 222 (Pubitemid 40615248)
12. B. Krasovitski, V. Frenkel, S. Shoham, and E. Kimmel Intramembrane cavitation as a unifying mechanism for ultrasound-induced bioeffects Proc. Natl. Acad. Sci. U. S. A. 108 2011 3258 3263
13. I. Lentacker, B. Geers, J. Demeester, S.C. De Smedt, and N.N. Sanders Design and evaluation of doxorubicin-containing microbubbles for ultrasound-triggered doxorubicin delivery: cytotoxicity and mechanisms involved Mol. Ther. 18 2010 101 108
14. F. Yan, L. Li, Z. Deng, Q. Jin, J. Chen, W. Yang, C.K. Yeh, J. Wu, R. Shandas, X. Liu, and H. Zheng Paclitaxel-liposome-microbubble complexes as ultrasound-triggered therapeutic drug delivery carriers J. Control. Release 166 2013 246 255
15. H. Wang, and J.A. Joseph Quantifying cellular oxidative stress by dichlorofluorescein assay using microplate reader Free Radic. Biol. Med. 27 1999 612 616 (Pubitemid 29408648)
16. A. Rogan, T. Hamilton, R. Young, R. Klecker, and R. Ozols Reversal of adriamycin resistance by verapamil in human ovarian cancer Science 224 1984 994 996 (Pubitemid 14105761)
17. E.P. Rogakou, W. Nieves-Neira, C. Boon, Y. Pommier, and W.M. Bonner Initiation of DNA fragmentation during apoptosis induces phosphorylation of H2AX histone at serine 139 J. Biol. Chem. 275 2000 9390 9395 (Pubitemid 30185164)
18. T.P. Miller, T.M. Grogan, W.S. Dalton, C.M. Spier, R.J. Scheper, and S.E. Salmon P-glycoprotein expression in malignant lymphoma and reversal of clinical drug resistance with chemotherapy plus high-dose verapamil J. Clin. Oncol. 9 1991 17 24
19. J. Wu, and W.L. Nyborg Ultrasound, cavitation bubbles and their interaction with cells Adv. Drug Deliv. Rev. 60 2008 1103 1116
20. A. El Ouahabi, M. Thiry, V. Pector, R. Fuks, J.M. Ruysschaert, and M. Vandenbranden The role of endosome destabilizing activity in the gene transfer process mediated by cationic lipids FEBS Lett. 414 1997 187 192 (Pubitemid 27389360)
21. A.L. Seynhaeve, B.M. Dicheva, S. Hoving, G.A. Koning, and T.L. Ten Hagen Intact Doxil is taken up intracellularly and released doxorubicin sequesters in the lysosome: evaluated by in vitro/in vivo live cell imaging J. Control. Release 172 2013 330 340
22. B.D.M. Meijering, L.J.M. Juffermans, A. Van Wamel, R.H. Henning, I.S. Zuhorn, M. Emmer, A.M.G. Versteilen, W.J. Paulus, W.H. Van Gilst, K. Kooiman, N. De Jong, R.J.P. Musters, L.E. Deelman, and O. Kamp Ultrasound and microbubble-targeted delivery of macromolecules is regulated by induction of endocytosis and pore formation Circ. Res. 104 2009 679-U226
23. D.A. Gewirtz A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin Biochem. Pharmacol. 57 1999 727 741 (Pubitemid 29094544)
24. R. Banerjee, P. Tyagi, S. Li, and L. Huang Anisamide-targeted stealth liposomes: a potent carrier for targeting doxorubicin to human prostate cancer cells Int. J. Cancer 112 2004 693 700 (Pubitemid 39425952)
25. L.J.M. Juffermans, P.A. Dijkmans, R.J.P. Musters, C.A. Visser, and O. Kamp Transient permeabilization of cell membranes by ultrasound-exposed microbubbles is related to formation of hydrogen peroxide Am. J. Physiol. Heart Circ. Physiol. 291 2006 H1595 H1601
26. G. Basta, L. Venneri, G. Lazzerini, E. Pasanisi, M. Pianelli, N. Vesentini, S. Del Turco, C. Kusmic, and E. Picano In vitro modulation of intracellular oxidative stress of endothelial cells by diagnostic cardiac ultrasound Cardiovasc. Res. 58 2003 156 161 (Pubitemid 36351633)
27. H. Mizutani, S. Tada-Oikawa, Y. Hiraku, M. Kojima, and S. Kawanishi Mechanism of apoptosis induced by doxorubicin through the generation of hydrogen peroxide Life Sci. 76 2005 1439 1453 (Pubitemid 40164773)
28. P. Ubezio, and F. Civoli Flow cytometric detection of hydrogen peroxide production induced by doxorubicin in cancer cells Free Radic. Biol. Med. 16 1994 509 516 (Pubitemid 24105999)
29. K. Milowska, and T. Gabryelak Reactive oxygen species and DNA damage after ultrasound exposure Biomol. Eng. 24 2007 263 267 (Pubitemid 46755011)
30. H. Mizutani, S. Oikawa, Y. Hiraku, M. Murata, M. Kojima, and S. Kawanishi Distinct mechanisms of site-specific oxidative DNA damage by doxorubicin in the presence of copper(II) and NADPH-cytochrome P450 reductase Cancer Sci. 94 2003 686 691 (Pubitemid 37160925)
31. U.A. Germann P-glycoprotein - a mediator of multidrug resistance in tumour cells Eur. J. Cancer 32A 1996 927 944
32. Y. Donmez, L. Akhmetova, O.D. Iseri, M.D. Kars, and U. Gunduz Effect of MDR modulators verapamil and promethazine on gene expression levels of MDR1 and MRP1 in doxorubicin-resistant MCF-7 cells Cancer Chemother. Pharmacol. 67 2011 823 828
33. B.M. Gruber, I. Bubko, J. Krzyszton-Russjan, and E.L. Anuszewska Synergistic action of doxorubicin and sulindac in human cervix carcinoma cells - studies on possible mechanisms Med. Sci. Monit. 16 2010 BR45 BR51
34. A.A. Brayman, M.L. Coppage, S. Vaidya, and M.W. Miller Transient poration and cell surface receptor removal from human lymphocytes in vitro by 1 MHz ultrasound Ultrasound Med. Biol. 25 1999 999 1008 (Pubitemid 29325775)
35. M.R. Bohmer, C.H. Chlon, B.I. Raju, C.T. Chin, T. Shevchenko, and A.L. Klibanov Focused ultrasound and microbubbles for enhanced extravasation J. Control. Release 148 2010 18 24